Study guide
7.4 Emergency Schedule II Prescriptions & Partial Filling Rules (CARA Act)
NABP MPJE Multistate Pharmacy Jurisprudence Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pharmacist Licensure & Reciprocity
1.1 Initial Licensure Requirements & Examinations 1.2 License Renewal, Continuing Education (CE) & Status 1.3 Reciprocity, License Transfer & Multistate Licensure 1.4 Disciplinary Actions, Board Hearings, Sanctions & Reinstatement
2 Chapter 2: Pharmacy Personnel Roles & Supervision Ratios
2.1 Pharmacy Interns: Scope of Practice, Supervision & Preceptor Rules 2.2 Pharmacy Technicians: Registration, Certification & Permitted Duties 2.3 Technician-to-Pharmacist Ratios & Delegated Tasks 2.4 Non-Pharmacist Personnel & Automated Dispensing Technology Roles
3 Chapter 3: Prescriptive Authority & Practitioner Categories
3.1 Physicians, Dentists, Veterinarians & Podiatrists: Prescribing Scope 3.2 Mid-Level Practitioners: APNs, PAs, Optometrists & Independent Authority 3.3 Out-of-State, Foreign & Deceased Practitioner Prescriptions 3.4 Self-Prescribing & Prescribing for Family Members
4 Chapter 4: Patient Counseling & Drug Utilization Review (OBRA '90)
4.1 OBRA '90 Mandates & Prospective Drug Utilization Review (DUR) 4.2 Patient Counseling Requirements, Offer-to-Counsel & Documentation 4.3 Patient Profile Requirements & Retrospective DUR
5 Chapter 5: Advanced Pharmacist Practice & Collaborative Agreements
5.1 Collaborative Practice Agreements (CPAs) & Protocol-Based Care 5.2 Pharmacist Immunization Authority & Vaccine Administration Protocols 5.3 Medication Therapy Management (MTM) & Point-of-Care Testing (POCT) 5.4 Hormonal Contraceptive, Naloxone & Post-Exposure Prophylaxis (PEP/PrEP) Prescribing
6 Chapter 6: Federal Controlled Substances Act (CSA) & Scheduling
6.1 Controlled Substance Schedules (CI through CV) & Classification Criteria 6.2 DEA Registration: Types, Forms (224, 225, 363) & Renewal Cycles 6.3 Scheduled Listed Chemical Products (SLCPs) & Combat Methamphetamine Epidemic Act (CMEA)
7 Chapter 7: Controlled Substance Prescriptions & Legitimate Purpose
7.1 Corresponding Responsibility & Red Flags for Improper Prescribing 7.2 Required Components of Controlled Substance Prescriptions 7.3 Electronic Prescriptions for Controlled Substances (EPCS) & Security Requirements 7.4 Emergency Schedule II Prescriptions & Partial Filling Rules (CARA Act)
8 Chapter 8: Controlled Substance Ordering, Inventory & Recordkeeping
8.1 Ordering Schedule II Substances: CSOS & DEA Form 222 Execution 8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness) 8.3 Theft, Significant Loss (DEA Form 106) & Disposal/Destruction (DEA Form 41) 8.4 Prescription Transfers & Prescription Drug Monitoring Programs (PDMPs)
9 Chapter 9: Federal Pure Food, Drug & Cosmetic Act (FD&C Act) & Drug Safety
9.1 Adulteration vs. Misbranding: Statutory Definitions & Legal Violations 9.2 Prescription Labeling Requirements, Expiration Dates & Side Effect Statements 9.3 Poison Prevention Packaging Act (PPPA) & Child-Resistant Container Exemptions 9.4 Drug Recalls (Class I, II, III) & Market Withdrawals 9.5 Drug Product Selection, Generic Substitution & DAW Codes 9.6 Returning & Reusing Dispensed Drugs: Restocking, Redispensing & Repository Programs
10 Chapter 10: Drug Supply Chain Security Act (DSCSA) & Commercial Distribution
10.1 DSCSA Track-and-Trace Requirements: Transaction Information & Statements 10.2 Suspect & Illegitimate Product Verification, Quarantine & Notification 10.3 Prescription Drug Marketing Act (PDMA): Samples, Reimportation & Wholesale Distribution
11 Chapter 11: Compounding Standards: USP <795>, <797> & <800>
11.1 Section 503A vs. 503B Compounding Facilities (DQSA Architecture) 11.2 Non-Sterile Compounding (USP <795>) & Beyond-Use Dating (BUD) 11.3 Sterile Compounding (USP <797>): Air Quality, Cleanrooms & BUD 11.4 Hazardous Drug Handling (USP <800>): Engineering Controls & Personal Protective Equipment
12 Chapter 12: Pharmacy Operational Security, Records & Telepharmacy
12.1 Physical Pharmacy Security, Alarm Systems & Keyholder Rules 12.2 Mandatory Pharmacy Records Retention & Audit Inspection Readiness 12.3 Central Fill, Automated Dispensing Systems (ADS) & Telepharmacy Operations 12.4 HIPAA Privacy Rule, Patient Records & Breach Notification Protocols
7.4 Emergency Schedule II Prescriptions & Partial Filling Rules (CARA Act)
Key Takeaways Explain This Topic AI
Emergency oral Schedule II prescriptions (21 CFR § 1306.11(d)) are restricted to the quantity necessary to treat the patient during the emergency period only.
The prescribing practitioner must deliver or postmark a written or EPCS cover prescription marked 'Authorization for Emergency Dispensing' within 7 days of an emergency oral C-II order, or the pharmacist must notify the DEA.
Under 21 CFR § 1306.13(a), if a pharmacy has insufficient stock for a C-II, the remaining portion must be filled within 72 hours or it is forfeited.
Under the CARA Act of 2016 (21 CFR § 1306.13(b)), partial fills requested by the patient or prescriber may be completed for up to 30 days from the prescription's issuance date.
For terminally ill or Long-Term Care Facility (LTCF) patients (21 CFR § 1306.13(c)), partial fills of C-II prescriptions are permitted for up to 60 days from the date of issuance.
Last updated: July 2026
Schedule II controlled substances are subject to the strictest statutory dispensing controls under federal law. As a general rule, Schedule II prescriptions require a written or compliant electronic prescription prior to dispensing and cannot contain refills. However, federal regulations establish narrow statutory exceptions for Emergency Oral Schedule II Prescriptions ( 21 CFR § 1306.11(d) ) and specific frameworks for Partial Filling of Schedule II Prescriptions ( 21 CFR § 1306.13 ). Mastery of these specific timeframes, reporting duties, and partial fill rules is heavily tested on the MPJE.
Emergency Oral Schedule II Prescriptions: 21 CFR § 1306.11(d)
In an emergency situation, a pharmacist may dispense a Schedule II controlled substance upon receiving oral authorization from a prescribing individual practitioner, provided specific regulatory criteria are satisfied.
1. Definition of an Emergency Situation
Under federal law, an emergency situation exists ONLY if the prescribing practitioner determines that:
Immediate administration of the Schedule II substance is necessary for proper treatment of the intended ultimate user.
No appropriate alternative treatment is available (including non-controlled drugs or Schedule III–V medications).
It is not reasonably possible for the prescribing practitioner to provide a written prescription or compliant EPCS order to the pharmacist prior to dispensing.
2. Statutory Emergency Requirements & Quantity Limits
Quantity Restriction : The quantity prescribed and dispensed MUST be limited to the amount adequate to treat the patient during the emergency period ONLY . Prescribing a 30-day supply under emergency oral provisions is illegal if the emergency period is only 3 days.
Immediate Transcription : The oral order must be immediately reduced to writing by the pharmacist and must contain all required 1306.05 prescription details except the practitioner's signature.
Prescriber Verification : The pharmacist must make a good-faith effort to verify the prescriber's identity and authority if the prescriber is unknown to the pharmacist.
3. The 7-Day Cover Prescription & Mandatory DEA Reporting
Within 7 days after authorizing an emergency oral Schedule II prescription, the prescribing practitioner MUST deliver or postmark a written or EPCS cover prescription to the dispensing pharmacist.
Annotation Requirement : The face of the cover prescription MUST bear the statement: 'Authorization for Emergency Dispensing' and the exact date of the oral order.
Attachment : Upon receipt, the pharmacist attaches this written cover prescription to the oral order previously transcribed.
MANDATORY DEA NOTIFICATION : If the prescribing practitioner fails to deliver or postmark a compliant cover prescription within the 7-day window , the pharmacist HAS A MANDATORY LEGAL DUTY to notify the local DEA Diversion Field Office . Failure of the pharmacist to report the prescriber voids the legal authority to dispense without a written prescription and exposes the pharmacist to federal enforcement action.
Schedule II Partial Filling Frameworks: 21 CFR § 1306.13
Partial filling of Schedule II prescriptions is governed by three distinct regulatory pathways under federal law. Conflating these timeframes is one of the most common errors on the MPJE.
Framework 1: Insufficient Stock (21 CFR § 1306.13(a))
Trigger : The pharmacy is unable to supply the full quantity prescribed due to inventory shortages.
Rule : The pharmacist may dispense a partial quantity. The remaining balance MUST be filled within 72 hours of the first partial dispensing.
Forfeiture Penalty : If the remaining balance is not supplied within 72 hours, the remaining quantity is forfeited . The pharmacist must notify the prescribing practitioner, and no further quantity can be dispensed without a brand new prescription.
Framework 2: Patient or Prescriber Request under the CARA Act of 2016 (21 CFR § 1306.13(b))
Trigger : The Comprehensive Addiction and Recovery Act (CARA) permits partial fills of Schedule II prescriptions at the request of the patient or the prescribing practitioner to reduce excess opioid supply in households.
Timeframe Limit : Partial fills may be requested and dispensed for up to 30 days from the date the prescription was ISSUED (written date).
Important Distinction : The 30-day clock starts on the date of issuance , NOT the date of the first partial fill.
Quantity Cap : The total quantity dispensed across all partial fills cannot exceed the total quantity prescribed.
Framework 3: Terminally Ill & Long-Term Care Facility (LTCF) Patients (21 CFR § 1306.13(c))
Trigger : Schedule II prescriptions written for patients in a Long-Term Care Facility (LTCF) or patients certified as terminally ill .
Timeframe Limit : Partial fills are permitted for up to 60 days from the date of issuance .
Documentation Requirements : The pharmacist MUST record on the prescription whether the patient is 'terminally ill' or an 'LTCF patient'. For each partial fill, the dispensing record must log: date of partial fill, quantity dispensed, remaining authorized quantity, and identification of the dispensing pharmacist.
Comprehensive Schedule II Dispensing & Partial Fill Comparison
Dispensing Scenario Governing Rule Maximum Timeframe Allowed Mandatory Actions / Penalties
Emergency Oral Order 21 CFR § 1306.11(d) Emergency period quantity only Cover rx postmarked in 7 days ; notify DEA if not received.
Insufficient Stock 21 CFR § 1306.13(a) Balance filled within 72 hours Remaining quantity forfeited after 72 hours; notify prescriber.
CARA Act Request 21 CFR § 1306.13(b) Up to 30 days from issuance date Dispensed at patient/prescriber request; total qty cap.
LTCF / Terminally Ill 21 CFR § 1306.13(c) Up to 60 days from issuance date Annotate 'terminally ill' or 'LTCF'; record individual fills.
Partial Filling of Schedules III, IV, and V: 21 CFR § 1306.23
Partial filling of Schedule III, IV, and V prescriptions is fully permissible under federal regulations, provided:
Each partial fill is recorded in the same manner as a refill.
The total quantity dispensed in all partial fills does not exceed the total quantity prescribed.
No dispensing occurs beyond 6 months from the date of issuance for Schedule III and IV medications.